Synthesis and preliminary evaluation of [11C]KF17837, a selective adenosine A2A antagonist

Applied Radiation and Isotopes

Volumn 47, Issue 5-6, 1996, Pages 507-511

  Ishiwata, Kiichi ^a   Noguchi, Junko ^a,b   Toyama, Hinako ^a   Sakiyama, Yojiro ^a   Koike, Nobuaki ^c   Ishii, Shin Ichi ^a   Oda, Keiichi ^a   Endo, Kazutoyo ^b   Suzuki, Fumio ^c   Senda, Michio ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

^c KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS; BRAIN; CAMERAS; CARDIOVASCULAR SYSTEM; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVE MATERIALS; RADIOACTIVITY; SYNTHESIS (CHEMICAL);

ADENOSINE ANTAGONIST; ADENOSINE RECEPTORS; GAMMA CAMERA; HEART; MYOCARDIAL UPTAKE; RADIOLIGAND; SPECIFIC STRIATAL UPTAKE;

AROMATIC COMPOUNDS;

8 (3,4 DIMETHOXYSTYRYL) 7 METHYL 1,3 DIPROPYLXANTHINE; CARBON 11;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; CARBON RADIOISOTOPES; HEART; MALE; MICE; MYOCARDIUM; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED; XANTHINES;

EID: 0030152887     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8043(95)00295-2     Document Type: Article

References (19)

1. 3H]NECA in rat striatal membranes. Mol. Pharmacol. 29, 331.
2. 3H]cyclohexyladenosine. J. Neurosci. 2, 1230.
3. 1 antagonist. Appl. Radiat. Isot. 46, 1009.
4. 11C]semotiadil, a benzothiazine calcium antagonist. Appl. Radiat. Isot. 45, 439.
5. Ishiwata K., Ishii S. and Senda M. (1993) HPLC using physiological saline for the quality control of radiopharmaceuticals used in PET studies. Appl. Radiat. Isot. 44, 1119.
6. 3H]-CGS 21680. Eur. J. Pharmacol. 168, 243.
7. 2A receptor antagonist with anticataleptic activity. Eur. J. Pharmacol. 256, 263.
8. 2 receptors. Trends Pharmacol. Sci. 12, 326.
9. 2 receptor antagonist. Eur. J. Pharmacol. 267, 335.
10. 2 receptor antagonist, to rat brain membranes. Mol. Pharmacol. 46, 817.
11. 2 antagonist, (E)-1,3-dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthine. J. Med. Chem. 36, 3731.
12. Ogihara-Umeda I., Sasaki T., Toyama H., Oda K., Senda M. and Nishigori H. (1994) Rapid tumor imaging by active background reduction using biotin-bearing liposomes and avidin. Cancer Res. 54, 463.
13. Olsson R. A. and Pearson J. D. (1990) Cardiovascular purinoceptors. Physical. Rev. 70, 761.
14. 3H]-CGS21680 as a ligand. Naunyn-Schmied. Arch. Pharmacol. 342, 85.
15. Pollack A. E., Harrison M. B., Wooten G. F. and Fink J. S. (1993) Differential localization of A2a adenosine receptor mRNA with D1 and D2 dopamine receptor mRNA in striatal output pathways following a selective lesion of striatonigral neurons. Brain Res. 631, 161.
16. 2 receptor mRNA in the human brain. Neurosci. Lett. 130, 177.
17. 2 antagonists. J. Med. Chem. 35, 2342.
18. Watanabe M., Uchida H., Okada H., Shimizu K., Satoh N., Yoshikawa E., Ohmura T., Yamashita T. and Tanaka E. A high resolution PET for animal studies. IEEE Trans. Med. Imag. 11, 577.
19. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 89, 7432.